서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Issue Date

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 41 to 60 of 4,167

Issue DateTitle / Author(s) / CitationFileAltmetrics
2023-12
HERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Platinum-Based Chemotherapy
DOI
2023-12
전국 응급의료기관의 기계 심폐소생술 장치 사용 현황에 대한 보고

박희수; 서길준; 김태균; 김하영; 김주원; 최명재; 왕가온소래

대한응급의학회지, Vol.34 No.6, pp.467-486

2023-12
Exploration of the interplay between spatially distinct microbial habitats through comparative analysis

Kim, Hyunji; Hong, Jin Sil; Yun, Pil Young; Hwang, Kyung Gyun; Kim, Keun Suh; Lee, Hyo Jung; Park, Kyoung Un

Journal of Oral Microbiology, Vol.15 No.1, p. 2229693

DOI
2023-11
The prognostic value of a combined immune score in tumor and immune cells assessed by immunohistochemistry in triple-negative breast cancer
DOI
2023-11
Activation of Lysosomal Function Ameliorates Amyloid-β-Induced Tight Junction Disruption in the Retinal Pigment Epithelium
DOI
2023-11
The Factors Affecting Longitudinal Course of Posttraumatic Stress Disorder Symptoms in Sexual Assault Victims
DOI
2023-11
Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial
DOI
2023-11
Adding Ovarian Suppression to Tamoxifen for Premenopausal Women with Hormone Receptor-Positive Breast Cancer after Chemotherapy: An 8-Year Follow-Up of the ASTRRA Trial
DOI
2023-11
Trastuzumab Deruxtecan in Patients with HER2-Mutant Metastatic Non-Small-Cell Lung Cancer: Primary Results from the Randomized, Phase II DESTINY-Lung02 Trial
DOI
2023-11
Allelic hierarchy for USH2A influences auditory and visual phenotypes in South Korean patients
DOI
2023-11
Tracking antigen-specific TCR clonotypes in SARS-CoV-2 infection reveals distinct severity trajectories
DOI
2023-11
Validity of measurement of femoral anteversion angle using FEMORA® software based on two-dimensional radiographic imaging examination femur in children with cerebral palsy in Indonesia
DOI
2023-10
Prevention of severe lung immunopathology associated with influenza infection through adeno-associated virus vector administration

Choi, Eun Ah; Park, Hi Jung; Choi, Sung Min; Lee, Jae Il; Jung, Kyeong Cheon

Laboratory Animal Research,Vol.39(1):26

view fileDOI
2023-10
What is the impact of ones chronic illness on his or her spouses future chronic illness: a community-based prospective cohort study
view fileDOI
2023-10
Targeting CD73 to Overcomes Resistance to First-Generation EGFR Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer

Kim, Miso; Kim, Soyeon; Yim, Jeemin; Keam, Bhumsuk; Kim, Tae Min; Jeon, Yoon Kyung; Kim, Dong-Wan; Heo, Dae Seog

Cancer Research and Treatment, Vol.55 No.4, pp.1134-1143

DOI
2023-10
ILUSTRO: Phase II Multicohort Trial of Zolbetuximab in Patients with Advanced or Metastatic Claudin 18.2–Positive Gastric or Gastroesophageal Junction Adenocarcinoma
DOI
2023-10
Prognostic utility of body composition parameters based on computed tomography analysis of advanced non-small cell lung cancer treated with immune checkpoint inhibitors
DOI
2023-10
Recent Developments in the Therapeutic Landscape of Advanced or Metastatic Hormone Receptor-Positive Breast Cancer

Lee, Eunice Yoojin; Lee, Dae-Won; Lee, Kyung-Hun; Im, Seock-Ah

Cancer Research and Treatment, Vol.55 No.4, pp.1065-1076

DOI
2023-10
A Phase II Study of Osimertinib in Patients with Advanced-Stage Non-Small Cell Lung Cancer following Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR TKI) Therapy with EGFR and T790M Mutations Detected in Plasma Circulating Tumour DNA (PLASMA Study)
DOI
2023-10
Amivantamab plus lazertinib in osimertinib-relapsed <i>EGFR</i>-mutant advanced non-small cell lung cancer: a phase 1 trial
DOI
1 2 3 4 5 6209